Keyphrases
Interleukin-2
100%
Cutaneous T-cell Lymphoma
100%
Interleukin-15 (IL-15)
100%
CD4+ T Lymphocytes
100%
Rapamycin
100%
Induced Activation
100%
Mammalian Target of Rapamycin (mTOR)
71%
Lymphoma Cells
42%
AKT1
42%
Preactivated
14%
Large Cell Transformation
14%
Apoptotic Rate
14%
Mitogen
14%
T-cell Lymphoma
14%
JAK3
14%
Janus Kinase 1 (JAK1)
14%
Signaling Pathway
14%
Nutrient-dependent
14%
Stage-dependent
14%
Cell Proliferation
14%
Activation Mechanism
14%
Lymphoma
14%
CD4+ T Cells
14%
Interleukin-21 (IL-21)
14%
Functional Status
14%
Therapeutic Target
14%
Leukemia
14%
Medicine and Dentistry
CD4+ T Lymphocyte
100%
Interleukin 2
100%
Interleukin 15
100%
Cutaneous T Cell Lymphoma
100%
Protein Kinase B
57%
Lymphoma Cell
42%
Cell Line
28%
Cell Signaling Pathway
14%
Mitogenic Agent
14%
Kinase
14%
T-Cell Lymphoma
14%
Cell Proliferation
14%
Large Cell
14%
T-Helper Cell
14%
Cytokine Signaling
14%
Cell Transformation
14%
Functional Status
14%
Immunology and Microbiology
Interleukin 15
100%
Sirolimus
100%
Interleukin 2
100%
CD4+ T Lymphocyte
100%
T Cell
100%
Lymphoma Cell
37%
Cell Line
25%
Apoptosis Rate
12%
Functional Status
12%
T-Helper Cell
12%
Cell Proliferation
12%
Cytokine Signaling
12%
Mitogen
12%
Cell Transformation
12%
Biochemistry, Genetics and Molecular Biology
Interleukin 15
100%
Interleukin 2
100%
CD4
100%
T Cell
100%
Protein Kinase B
40%
Cell Transformation
10%
Functional Status
10%
Apoptosis Rate
10%
Cytokine
10%
Cell Proliferation
10%